trending Market Intelligence /marketintelligence/en/news-insights/trending/MK-_2wRfx3G_WCKw4VoSSA2 content esgSubNav
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

Kura Oncology prices $50.1M common stock offering

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


Kura Oncology prices $50.1M common stock offering

Kura Oncology Inc. priced an underwritten public offering of 7,700,000 common shares at $6.50 apiece, for expected gross proceeds of about $50.1 million.

The company also granted underwriters a 30-day option to buy up to an additional 1,155,000 common shares.

The offering is expected to close on or around Aug. 16, subject to customary closing conditions.

Leerink Partners and Cowen are acting as joint book-running managers for the offering, with JMP Securities and Oppenheimer & Co. as co-lead managers.